Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices

Figures & data

Figure 1. Balance between risks of bleeding and thromboembolic complications.

Table 1. Directions for future research with regard to bleeding complications in LVAD patients.

Anticoagulant management	Management of bleeding
Safety of withholding antiplatelet therapy in selected cases to reduce the risk of bleeding	Evaluation of specific measurements to target acquired von Willebrand syndrome
Decreasing the INR threshold for bridging anticoagulant therapy	Evaluation of specific measurements to target angiodysplasia and arteriovenous malformations
Evaluation of measurements to reduce pump speed in order to improve LVAD pulsatility	Establishing the optimal timing of reintroducing anticoagulants following (intracranial) hemorrhage
Optimal management of LVAD pump thrombosis